Key terms
About CMRX
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CMRX news
Mar 22
11:33am ET
Biotech Alert: Searches spiking for these stocks today
Mar 21
8:42am ET
Chimerix Board Changes: Machado Resigns, Kozin Appointed
Mar 21
7:19am ET
Chimerix appoints Kozin to board of directors
Mar 05
1:31am ET
Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX), DENTSPLY SIRONA (XRAY) and Karuna Therapeutics (KRTX)
Mar 01
6:30am ET
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Bio-Rad Laboratories (BIO)
Feb 29
10:00pm ET
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Chimerix (CMRX)
Feb 29
3:10pm ET
Analysts’ Top Healthcare Picks: Chimerix (CMRX), MoonLake Immunotherapeutics (MLTX)
Feb 29
11:55am ET
Buy Rating Affirmed for Chimerix Amid Progress in Dordaviprone’s Phase III Study and Strong Financial Outlook
Feb 29
9:24am ET
Chimerix files $250M mixed securities shelf
Feb 29
8:14am ET
Chimerix Unveils New Corporate Presentation for Investors
Feb 29
7:04am ET
Chimerix reports Q4 EPS (20c), consensus (24c)
Feb 15
11:05am ET
Biotech Alert: Searches spiking for these stocks today
Jan 08
10:15pm ET
Lightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)
Dec 29
7:03am ET
Chimerix appoints Lisa Decker to board of directors
No recent press releases are available for CMRX
CMRX Financials
Key terms
Ad Feedback
CMRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CMRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range